A Review on the Biotechnological Applications of the Operational Group Bacillus amyloliquefaciens

Bacteria under the operational group Bacillus amyloliquefaciens (OGBa) are all Gram-positive, endospore-forming, and rod-shaped. Taxonomically, the OGBa belongs to the Bacillus subtilis species complex, family Bacillaceae, class Bacilli, and phylum Firmicutes. To date, the OGBa comprises four bacterial species: Bacillus amyloliquefaciens, Bacillus siamensis, Bacillus velezensis and Bacillus nakamurai. They are widely distributed in various niches including soil, plants, food, and water. A resurgence in genome mining has caused an increased focus on the biotechnological applications of bacterial species belonging to the OGBa. The members of OGBa are known as plant growth-promoting bacteria (PGPB) due to their abilities to fix nitrogen, solubilize phosphate, and produce siderophore and phytohormones, as well as antimicrobial compounds. Moreover, they are also reported to produce various enzymes including α-amylase, protease, lipase, cellulase, xylanase, pectinase, aminotransferase, barnase, peroxidase, and laccase. Antimicrobial compounds that able to inhibit the growth of pathogens including non-ribosomal peptides and polyketides are also produced by these bacteria. Within the OGBa, various B. velezensis strains are promising for use as probiotics for animals and fishes. Genome mining has revealed the potential applications of members of OGBa for removing organophosphorus (OPs) pesticides. Thus, this review focused on the applicability of members of OGBa as plant growth promoters, biocontrol agents, probiotics, bioremediation agents, as well as producers of commercial enzymes and antibiotics. Here, the bioformulations and commercial products available based on these bacteria are also highlighted. This review will better facilitate understandings of members of OGBa and their biotechnological applications.


Introduction
In 1943, a Japanese scientist, Juichiro Fukumoto, first isolated Bacillus amyloliquefaciens from the soil. The species is named after its unique character because it produced (faciens) a liquefying (lique) α-amylase (amylo) [1,2]. Later, B. amyloliquefaciens was combined with the closely related Bacillus subtilis and Bacillus licheniformis into the B. subtilis species complex, based on phylogenetic and phenetic evidence [3]. From the B. subtilis species complex, it can be further sub-grouped into the operational group B. amyloliquefaciens (OGBa) that

Identification and Characterization
Bacterial species from the OGBa are all Gram-positive bacteria and motile by peritrichous flagella. They are endospore-forming bacteria from the B. subtilis species complex. For many years, the speciation of OGBa within the B. subtilis species complex has been uncertain, often leading to erroneous and variable results. They are difficult to distinguish using classical taxonomy parameters: morphological and physiological characteristics, cell wall compositions, 16S ribosomal RNA sequence, guanine-cytosine (G+C) content, fatty acid methyl esters (FAME) and DNA-DNA hybridization (DDH) [9]. Therefore, the taxonomic status of the bacterial species belonging to the OGBa is constantly causing confusion to researchers, especially for non-professional taxonomy researchers.
It is worth mentioning that some studies have used protein-coding genes in order to further ascertain the degree of relatedness of the OGBa within the B. subtilis species complex [10,11]. The highly conserved DNA gyrase subunit B (gyrB), signal transduction histidine kinase CheA (cheA) and RNA polymerase β-subunit (rpoB) were used for the study of speciation within the B. subtilis species complex before the advent of multilocus sequence analysis (MLSA) [11][12][13]. The taxonomical status of the members of OGBa has been solved by genome-based [4] and gene-derived [14] phylogeny analyses. The OGBa comprised four species: (i) B. amyloliquefaciens; (ii) B. siamensis; (iii) B. velenzensis; and (iv) B. nakamurai, as confirmed by cladistic analysis (Figure 1; Table 1).

Figure 1.
Neighbor-joining phylogenetic tree based on complete rpoB nucleotide sequences of bacterial species under the B. subtilis species complex. Evolutionary analyses were conducted using the MEGAX software [15]. The optimal tree with the sum of branch length = 0.66533958 is shown. The evolutionary distances were computed using the p-distance method. Bootstrap values, based on 1000 repetitions, are indicated at the branch points. The analysis involved 19 nucleotide sequences. There were 3534 positions in the final dataset. Bar, 0.02 substitutions per nucleotide position. Bacillus cereus ATTC 14579 T was used as the outgroup.

Ecology, Isolation and Cultivation
The ability to produce endospores when facing harsh conditions allowed the members of the operational group to survive in various niches including soil, animal faeces, plants, food, bee products, drugs, air, and the aquatic environments (Table S1). Evidently, the members of OGBa had been directly isolated from rare dormant volcanic soils [19], mango orchards [20] and animal faeces [21,22]. They had also been isolated from plant parts including fruits (such as lemons [23] and apples [24]), roots (such as Peruvian ground cherry [25] and peanut roots [26]) and leaves (such as lucerne [27] and camphor leaves [28]).
Moreover, traditional fermented foods including bibimbap [29], douchi [30], and doenjang [31] were reported as the sources of isolation of bacteria from this operational group. They also were isolated from bee products [32][33][34], heroin [35], and air [36]. In other related studies, bacteria of this operational group have been isolated from water [37], seawater [38] and sea sediment [39]. Chicken [40] and fish intestines [41] were also reported as the sources of origin for members of this operational group.

Genome and Its Arrangement
In 2019, 254 bacterial strain genomes which had been deposited in the NCBI database were reported as belonging to the OGBa [6]. Some of the examined strains were found to contain plasmids (Table S1). Most of the reported strains had only one plasmid, except for B. velezensis 157, B. velezensis DKU_NT_04, and B. velezensis NJAU-Z9 (all contained two plasmids), and B. velezensis LB002 (which contained three plasmids). Interestingly, some studies have focused on the functionality of the genes carried by the plasmid. For instance, the B. velezensis S499 plasmid, pS499, was reported as containing a rap-phr cassette. This cassette encoded for the regulator aspartate phosphatase (rap) and the Rap regulatory peptide (phr) with a role in governing protease secretion, growth and motility, biofilm formation and production of surfactin [42]. Meanwhile, B. amyloliquefaciens LL3 plasmid, pMC1, has a 6.8 kbp plasmid that includes a rap which is not homologous to the pS499 [42]. The hypothetical rap and the origin of replication of the pMC1 plasmid were cloned into the pKSV7, vector which brought about the production of plasmid-cured strains. The plasmidcured strains have increases in glutamate-independent poly-γ-glutamic acid production by 6% as compared to the B. amyloliquefaciens LL3 [43].
Genome analysis allowed for further biological studies on the members of OGBa. The genomic and metabolic features of the members of the group were similar; however, species-specific features including secondary metabolite biosynthesis-related and energy metabolism-related genes were also identified [4,44]. Secondary metabolite biosynthesisrelated genes are enriched in B. velezensis, whereas energy metabolism-related genes are enriched in B. amyloliquefaciens. In the core-genome, B. velezensis harbors more genes involved in the biosynthesis of antimicrobial compounds as well as genes involved in D -galacturonate and D -fructuronate metabolisms compared to B. amyloliquefaciens and B. siamensis. Moreover, a xanthine oxidase gene cluster that is involved in metabolizing xanthine and uric acid to glycine and oxalureate was found in the core-genome of all the members of the group. Pan-genome analysis revealed the abilities of members of OGBa to metabolize diverse carbon sources aerobically or anaerobically. Their abilities to produce various metabolites such as lactate, ethanol, xylitol, diacetyl, acetoin, and 2,3-butanediol were also identified [44]. In addition, genome analysis suggested that the regions of genomic plasticity controlled the function and structure of the genome and governed the adaptations to different niches [45]. Genome analysis also enabled the prediction of uncharacterized gene clusters and assessed the capabilities of members of OGBa to produce antimicrobial compounds [6].

Plant Growth Promoters and Biocontrol Agents in Agriculture
In the agricultural sector, the biocontrol strategy has received great attention because it provides safe, environmentally friendly, long-lasting, and inexpensive alternatives [46]. The characterizations of the bacterial strains from the OGBa as biocontrol agents were determined based on their abilities to improve plant growth and health [47]. These abilities involve multiple mechanisms including direct (improve plant growth) and indirect (improve plant health) mechanisms ( Figure 2). Direct mechanisms involve nitrogen fixation, phosphate solubilization, siderophore production and phytohormone production (e.g., indole-3-acetic acid (IAA) and enzymes such as 1-amyclocyclopropane-1-carboxylate (ACC) deaminase). It has been reported that the co-inoculation of B. velezensis S141 with Bradyrhizobium diazoefficiens USDA110 into soybean resulted in enhanced nodulation and nitrogen fixation efficiency by producing larger nodules [48]. In another related study, the members of OGBa were able to solubilize phosphate, and produce IAA, ACC deaminase and siderophores [49][50][51].
Meanwhile, the indirect mechanism is mainly due to their biocontrol activities attributed to the production of antimicrobial compounds in response to biotic stress [52]. The members of OGBa produced antimicrobial compounds such as hydrogen cyanide (HCN) and cyclic lipopeptides such as surfactin used to inhibit the growth of pathogenic microbes [53,54]. The interactions of biocontrol agents with plant roots enhance plant resistance against some competing microbes including pathogenic bacteria, fungi and viruses. This phenomenon is termed as induced systemic resistance (ISR) [6,55]. The members of OGBa were proven to provide advantages to the agricultural sector by contributing to plant pathogen disease suppression. In plant disease management, the members of OGBa acted as plant growth-promoting bacteria (PGPB) that aid in the devel-opment of plants and reduce the proliferation of plant pathogens ( Table 2). The secretion of antimicrobial compounds such as surfactin from PGPB was suggested to trigger the pathways of ISR which contributed to the suppressive effect of plant immunity [56,57]. Surfactin was determined to act as elicitors of plant immunity and enhance resistance towards further pathogenesis in plants [47]. In the lettuce rhizosphere, increased production of surfactin by B. velezensis FZB42 in the axenic system was suggested to contribute to the disease suppression towards Rhizoctonia solani infection [53]. Similarly, the treatment using B. velezensis FZB42 in tobacco plants was suggested improve ISR and enhance plant height and fresh weight, while lowering the disease severity rating of the tobacco mosaic virus (TMV) [58]. B. velezensis ZF2 Corynespora leaf spot diseases C. sativus [80] Bacterial species from the OGBa are used in bioformulations. For instance, the bacterial strain B. velezensis FZB42 had been established as a model strain for plant growth promotion and as a biocontrol agent [55]. In 2019, tomato seeds coated with gum arabic as adhesive along with liquid bioformulations containing B. velezensis FZB42 showed great inhibitory effects against Fusarium solani infections under in vitro conditions. Increments in germination percentage and germination rate as compared with the control were also reported [81].
To date, there are a few bioformulations containing bacterial species from the OGBa available on the market (Table 3), such as SERENADE ® (Bayer Crop Science, Germany) which contains B. velezensis QST 713 (previously B. subtilis QST 713) and Double Nickel 55 TM (Certis Columbia, MD USA) which contains B. velezensis D747 (previously B. amyloliquefaciens D747) [55]. The application of SERENADE ® together with Fracture fungicide (CEV, Portugal), which contains BLAD polypeptide, had shown notable success in controlling Botrytis blossom blight disease infection in blueberries [82]. Application of Double Nickel 55 TM was found to be effective in controlling white mold in snap beans caused by Sclerotinia sclerotiorum. Double Nickel 55 TM , a biofungicide, was approved for organic vegetable production by the National Organic Program and Organic Materials Review Institute [83]. Apart from the aforementioned uses, the members of OGBa have also been applied as biocontrol agents against parasitic nematodes and protist pathogens. In 2008, B. velezensis FZB42 was reported to reduce nematode eggs in roots, juvenile worms in soil and plant galls on tomato [84]. Genomic study revealed that the whole genome of B. velezensis FZB42 encoded a diverse spectrum of different antimicrobial compounds able to suppress harmful nematodes living within the plant rhizosphere [85]. In controlling the protist pathogen, B. velezensis HB-26 (previously B. amyloliquefaciens HB-26) showed promising capability for controlling Plasmodiophora brassicae, a root-infecting protist that causes clubroot disease in brassica species. Many antimicrobial compounds showing specific activities against P. brassicae were found in the genome of B. velezensis HB-26 [86]. Overall, much more focus is still needed to fulfill the understanding of the molecular basis for the ability of members of OGBa to inhibit nematodes and protists beyond in silico genomic studies. Understanding such attributes will help to shed light on the functionalities as well as the biological roles of antimicrobial compounds from OGBa not only for improved plant growth but as biocontrol agents to minimize the proliferation of plant pathogens including viruses, bacteria, fungus, nematodes, and protists.

Source of Commercial Enzymes
Microbial enzymes such as α-amylase, protease, and lipase have been used in various biotechnological applications including textile applications, feed industry, food industry, and organic synthesis [87][88][89]. The U.S. Food and Drug Administration (FDA) in 1999 reported that enzymes such as α-amylase and protease originating from B. subtilis are Generally Recognized as Safe (GRAS) for use as direct food ingredients [90]. As members of the B. subtilis species complex, OGBa bacteria are a potent bacterial group due to their abilities to produce various types of enzymes including α-amylase, protease, lipase, cellulase, xylanase, pectinase, aminotransferase, barnase, peroxidase, and laccase (Table 4).

Antimicrobial Compounds Producer
The increment in the global antibiotic-resistant pathogens has led to the exploration of compounds with alternative therapeutic strategies [104]. The members of OGBa were reported to produce antimicrobial compounds used in the suppression of pathogens [45]. The antimicrobial compounds produced by the member of OGBa have been reviewed previously [8,105]. The members of OGBa produced some important antimicrobial compounds (Figure 3), including non-ribosomal peptides (surfactin, fengycin, bacillomycin-D, bacilysin and bacillibactin) and polyketides (bacillaene, macrolactin and difficidin) [6,105]. Non-ribosomal peptides produced by bacteria and fungi contain two or more moieties derived from amino acids [106]. The mode of action of non-ribosomal peptides involves the disruption to the cell membrane and inhibition on the transfer of peptidoglycan precursors to bactoprenol pyrophosphate [107]. In 2019, surfactins from B. velezensis 9D-6 were found to inhibit the in vitro growth of bacteria (B. cereus, C. michiganensis, Pantoea agglomerans, Ralstonia solanacearum, Xanthomonas campestris and Xanthomonas euvesicatoria) and fungi (Alternaria solani, Cochliobolus carbonum, F. oxysporum, F. solani, Gibberella pulicaris, Gibberella zeae, Monilinia fructicola, Pyrenochaeta terrestris and R. solani) pathogens [108]. In another related study, in silico genomic study of B. siamensis JFL15 had gene clusters involved in the biosynthesis of antimicrobial compounds. The LC-MS/MS analysis confirmed the presence of iturin A and bacillomycin F. Both compounds showed strong antifungal activities against Magnapothe grisea, R. solani and Colletotrichum gloeosporioides, as analyzed under in vitro conditions [109]. Moreover, the presence of fengycin, bacilysin, and bacillibactin had also been reported from B. velezensis OSY-S3 that showed inhibition activities against Listeria innocua, Escherichia coli, Penicillium sp., Cladosporium sp., and Staphylococcus aureus [110].
Polyketides are biopolymers of acetate and other short carboxylates that are biosynthesized by polyketide synthases, a natural metabolite produced by microorganisms and plants which possess various antifungal and antibacterial activities [111,112]. Since the discovery of polyketides (e.g., streptomycin in 1950), the exploration of new polyketides has assisted pharmaceutical companies in isolating new antibiotic-producing strains as the main sources of antibiotics [113]. Antibacterial polyketides including bacillaene, macrolactin and difficidin were reported from B. velezensis OSY-GA1 [109]. Moreover, B. velezensis YJ11-1-4 isolated from doenjang exhibited good antimicrobial activities against bacterial (B. cereus, E. coli, Listeria monocytogenes and S. aureus) and fungal (Aspergillus flavus subsp. flavus) foodborne pathogens. Genomic analysis reveals the presence of antibiotic biosynthesis operons including bacillaene, macrolactin and difficidin in the genome of B. velezensis OSY-GA1 [114]. Additionally, four new glycosylated macrolactin compounds, namely macrolactins O, P, Q and R, had been isolated from the liquid cultures of B. velezensis AH159-1. These compounds inhibited S. aureus peptide deformylase and also showed antibacterial activities against E. coli and S. aureus [115].

Potential as Probiotics
Probiotics are live microbial feed supplements that benefit the host animal by improving the microbial balance. Probiotics have become increasingly popular due to continuously expanding scientific evidence pointing to their beneficial effects on both humans and animals [116]. Within the OGBa, some B. velezensis strains are reported to display probiotic potential and have been applied as probiotics for animals [117]. For instance, B. velezensis H57 (previously B. amyloliquefaciens H57) isolated from lucerne was first investigated in the research to prevent fungal spoilage of hay [118]. Because it is an endospore-forming bacterium able to produce antimicrobial compounds, B. velezensis H57 was commercialized as a spoilage control agent under the product name HayRite™ (Biocare and BASF, Australia). Interestingly, sheep and cattle fed on HayRite™ showed improvements in digestibility and nitrogen retention leading to increased weight gain [118]. Genomically, the potential of B. velezensis H57 to synthesize antimicrobial compounds including surfactin (srfABCD), iturin (ituABCD), bacillomycin D (bmyABC), fengycin (fenABCDE), macrolactin (mlnABCDEFGHI), difficidin (dfnABCDEFGHIJ) and bacillaene (baeEDLMNJRS) were suggested to facilitate the probiotic effects of B. velezensis H57 [27]. In another related study, B. velezensis FTC01 manifested itself as a probiotic [119]. Genes coding for hydrolases (peptidases, phytases and glycosidases) that can improve feed digestion and prevent intestinal disorders are present in the genome of B. velezensis FTC01. Additionally, peptidylprolyl isomerase (prsA) gene (a gene that is involved in bacterial adhesion and signaling of biofilm formation in the host gut) was also found. Moreover, in silico genome analysis of B. velezensis FTC01 proved the presence of gene clusters involved in the synthesis of antimicrobial peptides. Similarly, gene clusters involved in the synthesis of antimicrobial peptides were also found in the genome of B. velezensis JT3-1, a probiotic strain isolated from faeces of the domestic yak [21]. The antimicrobial activity of B. velezensis JT3-1 was confirmed using an antimicrobial assay. Strain JT3-1 manifested strong antagonistic activities against various intestinal pathogenic flora including L. monocytogenes, S. aureus, E. coli, Salmonella typhimurium, Mannheimia haemolytica, Staphylococcus hominis, Clostridium perfringens and Mycoplasma bovis.
B. velezensis B-1895 (previously B. amyloliquefaciens B-1895) has been commercially used as a probiotic in the fish industry, particularly for Alburnus leobergi [120,121]. Its probiotic potential was proven thought the Ames test (reported as non-mutagenic) and antimicrobial activities (against Streptococcus intermedius and Porphyromonas gingivalis). Moreover, the endospores of B. velezensis B-1895 were found tolerant to 0.3% (w/v) bile salts and survived incubation for 4 h in MRS broth at pH 2.0-3.0. Overall, the results suggested the potential of B. velezensis B-1895 as a fish probiotic [122]. In another related study, B. velezensis JW also manifested itself as a fish probiotic [123]. Strain JW showed antibacterial activities against a broad range of bacterial fish pathogens (Aeromonas hydrophila, Aeromonas salmonicida, Lactococcus garvieae, Streptococcus agalactiae and Vibrio parahemolyticus). Dietary administration of B. velezensis JW induced an immune response in Carassius auratus. The immune-related genes in C. auratus such as interferon gamma gene (IFNγ), tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), interleukin-4 (IL-4) and interleukin-10 (IL-10) were found to be upregulated by B. velezensis JW-supplemented diets. It is noteworthy that C. auratus fed with B. velezensis JW-supplemented diets showed improvements in survival rate after A. hydrophila infection. This was supported genomically by the presence of antimicrobial gene clusters in the genome of B. velezensis JW [122]. Moreover, a potential probiotic effect of B. velezensis V4 on the growth performance of Oncorhynchus mykiss had also been investigated [124]. Cell-free supernatant of B. velezensis V4 with anti-A. salmonicida was shown to contain antimicrobial compounds including iturin, macrolactin and difficidin. The mortality rate of O. mykiss was reduced by 27% and the weight gain ratio was increased by 71% through the 1% (v/w) addition of B. velezensis V4. Overall, the findings demonstrated that B. velezensis V4 was an effective probiotic in O. mykiss.
The commercialization of B. amyloliquefaciens as a probiotic in aquaculture is not as common compared to its agricultural applications (Table 3). Ecobiol ® Soluble Plus, is one of the commercial probiotic products reported as containing B. amyloliquefaciens at a concentration of 10 9 CFU/g, specifically formulated for applications in poultry and swine, as well as in aquaculture. There was research conducted on the commercial probiotic Ecobiol ® Soluble to observe its positive effects on the biofloc culture of Litopenaeus vannamei and its benefits on water quality, growth performance and the immune system of shrimps. Three doses of probiotic (9.48 × 10 4 , 1.90 × 10 5 and 3.79 × 10 5 CFU/g) were applied to the culture water for 42 days. At the end of the trial, there was no significant improvement in the water quality. However, it showed notable changes in the immune system of the shrimp. As compared to the control treatment, there was an increase in the total protein concentration and granular hemocytes, and a decrease in the cell number with apoptosis in the hemolymph in all treatments. Therefore, other than being mixed with feed, B. amyloliquefaciens in the commercial probiotic Ecobiol ® Soluble Plus could also be applied directly to the culture system; this research proved it provided better resistance to shrimps against the outbreak of pathogens in shrimp biofloc systems [125].
There is much ongoing research on the development and formulations of bacterial strains belonging to the OGBa as potential probiotics for commercialization purposes in the aquaculture industry. Most of the studies have emphasized probiotic feed formulations, feeding trials on a small scale before moving to field trials. For instance, dietary inclusion of B. amyloliquefaciens at 10 6 CFU/g fed to zebra fish improved the expression levels of metabolism-related genes, enzyme activities and oxidative stress-related genes in the fish liver as well as enhanced their immune resistance against pathogenic A. hydrophila and S. agalactiae. In addition, the strain of B. amyloliquefaciens used in this study was able to express recombinant xylanase, an important enzyme that aided in better feed digestibility and efficiency [126]. In another related study, the administration of B. amyloliquefaciens (1 × 10 9 CFU/g), together with Spirulina platensis in formulated diet for tilapia, improved growth performance and feed utilization after a 60 day feeding trial. The mRNA level of the TNF-α gene and the transcription of SOD were considerably higher in tilapia fed with dietary B. amyloliquefaciens and S. platensis compared to the control group [127]. Moreover, B. amyloliquefaciens at a concentration of 10 6 CFU/mL provided significant protection to juvenile blue swimming crabs, Portunus pelagicus, when challenged with Vibrio harveyi in in vivo trials [128]. Nevertheless, further studies are necessary, mainly on probiotic formulation along with larger field trials, to strengthen the outcomes in order to be able to commercialize bacterial strains belonging to the OGBa for aquaculture use.
In vivo and field trials are critical in probiotic development. Occasionally, there were negative outcomes in in vivo studies which were carried out based upon the positive results acquired from the preliminary in vitro assays, which indicated the possibility of negative correlations between trials in vitro and in vivo. Hence, it is crucial to understand and to optimize various conditions in in vivo studies or field trials including the probiotic formulation which may affect the survival, colonization, proliferation, and interaction of the probiotic with the host in a certain environment [129].

Potential as Bioremediation Agents
The use of microorganisms as bioremediation agents has become a burgeoning trend [130]. To date, most research focused on the plant growth-promoting activity and antimicrobial compounds of OGBa is as described above. Interestingly, in 2019, B. amyloliquefaciens YP6 was reported to exhibit both plant growth-promoting activity and broadspectrum organophosphorus pesticide (OP) removal [131]. In silico genome analysis of B. amyloliquefaciens YP6 found it to contain a variety of promising genes, including phosphorus solubilizing and OP-degrading related genes (phoD, phoA, phrC, phoE, ycsE, bcrC and yvaK), indole-3-acetic acid synthesis related genes (amhX, cgeE and epsM), and siderophores synthesis related genes (entB, menF, entC and entA). The results hinted at the potential application of B. amyloliquefaciens YP6 in agricultural and environmental remediations. Overall, much more focus is still needed to understand the OP-degrading related genes beyond in silico genome analysis. Therefore, it is necessary to conduct further studies to determine the in vitro functional genomics and the OP-degrading enzyme activities of the members of OGBa. Understanding such attributes will help to shed light on the applicability of the OGBa in OPs degradation and in the bioremediation processes as a whole.

Concluding Remark and Future Perspectives
In conclusion, the progress of the research on the biotechnological applications of bacterial species that belong to OGBa is remarkable. The bacteria are important not only industrially, but also environmentally. A plethora of studies have addressed the abilities of the members of OGBa as plant growth-promoters, biocontrol agents, probiotics, bioremediation agents as well as producers of commercial enzymes and antibiotics. Moreover, the use of the bacteria in optimized bioformulations as well as the demonstration of the great success of the commercialized products give us hope towards more sustainable agricultural and aquacultural industries. Owing to the listed biotechnological applications and potentials, more research should be done focusing on the integration of system biology data derived from genomics, phenomics, proteomics, metabolomics and fluxomic analyses in order to expand our basic understanding on the versatility of the members of OGBa. Enabling the prediction of cellular functions and metabolites produced by the members of this operational group could provide fundamental knowledge towards the enhancement of the applications of their potentials in biotechnology and bioprocessing for the benefit of all.